PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to Bortezomib.

Wu, Dong; Miao, Jiyu; Hu, Jinsong; Li, Fangmei; Gao, Dandan; Chen, Hongli; Feng, Yuandong; Shen, Ying; He, Aili

Wu, Dong; Miao, Jiyu; Hu, Jinsong; Li, Fangmei; Gao, Dandan; Chen, Hongli; Feng, Yuandong; Shen, Ying; He, Aili.

Afiliação

Wu D; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Miao J; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Hu J; Department of Cell Biology and Genetics, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Li F; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Gao D; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Chen H; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Feng Y; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Shen Y; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
He A; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Front Oncol ; 11: 684232, 2021.

Article em En | MEDLINE | ID: mdl-34367968

Palavras-chave

PSMB7; WGCNA; drug resistance; multiple myeloma; proteasome inhibitor

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google